Interwest Venture Management Co
- SEC CIK
- 0001697720
- Latest filing
- Oct 20, 2023
Holdings in Q2 2021
Holdings as of Jun 30, 2021, filed Jul 26, 2021. Long positions only; changes compare share counts with Q1 2021.
- Positions
- 10
- −2 vs. Q1 2021
- Portfolio value
- $316.9M
- −$63.2M (−16.6%) vs. Q1 2021
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| PMVPPMV Pharmaceuticals, Inc. | COM | 4,969,911 | $169.8M | 53.6% | −500,000−9.1% | Reduced | History |
| AIC3.ai, Inc. | Stock | 866,774 | $54.2M | 17.1% | −520,000−37.5% | Reduced | History |
| REALTheRealReal, Inc. | COM | 2,354,080 | $46.5M | 14.7% | 00.0% | Unchanged | History |
| GKOSGLAUKOS Corp | COM | 346,364 | $29.4M | 9.3% | 00.0% | Unchanged | History |
| EIGREiger BioPharmaceuticals, Inc. | COM | 764,918 | $6.52M | 2.1% | 00.0% | Unchanged | History |
| AGTCApplied Genetic Technologies Corp | COM | 1,404,515 | $5.49M | 1.7% | 00.0% | Unchanged | History |
| CDTXCidara Therapeutics, Inc. | COM | 1,356,813 | $2.74M | 0.9% | 00.0% | Unchanged | History |
| VEROVenus Concept Inc. | COM | 658,657 | $2.05M | 0.6% | 00.0% | Unchanged | History |
| XENEXenon Pharmaceuticals Inc. | COM | 8,293 | $148.0K | <0.1% | 00.0% | Unchanged | History |
| DAREDare Bioscience, Inc. | COM | 50,368 | $95.0K | <0.1% | 00.0% | Unchanged | History |
Sold out since Q1 2021 (2)
Positions held at the end of Q1 2021 that are gone from this filing.